- Home
- ADTX vs ELAB Comparison
ADTX vs ELAB Comparison
Compare ADTX & ELAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ADTX
- ELAB
- Stock Information
- Founded
- ADTX 2017
- ELAB 2020
- Country
- ADTX United States
- ELAB United States
- Employees
- ADTX N/A
- ELAB N/A
- Industry
- ADTX Biotechnology: Pharmaceutical Preparations
- ELAB
- Sector
- ADTX Health Care
- ELAB
- Exchange
- ADTX Nasdaq
- ELAB Nasdaq
- Market Cap
- ADTX 3.1M
- ELAB 3.2M
- IPO Year
- ADTX 2020
- ELAB 2023
- Fundamental
- Price
- ADTX $1.19
- ELAB $1.88
- Analyst Decision
- ADTX
- ELAB
- Analyst Count
- ADTX 0
- ELAB 0
- Target Price
- ADTX N/A
- ELAB N/A
- AVG Volume (30 Days)
- ADTX 466.9K
- ELAB 136.7K
- Earning Date
- ADTX 08-18-2025
- ELAB 08-18-2025
- Dividend Yield
- ADTX N/A
- ELAB N/A
- EPS Growth
- ADTX N/A
- ELAB N/A
- EPS
- ADTX N/A
- ELAB N/A
- Revenue
- ADTX $55,323.00
- ELAB N/A
- Revenue This Year
- ADTX $15,768.94
- ELAB N/A
- Revenue Next Year
- ADTX N/A
- ELAB N/A
- P/E Ratio
- ADTX N/A
- ELAB N/A
- Revenue Growth
- ADTX N/A
- ELAB N/A
- 52 Week Low
- ADTX $0.81
- ELAB $1.81
- 52 Week High
- ADTX $14,800.00
- ELAB $546.00
- Technical
- Relative Strength Index (RSI)
- ADTX 49.24
- ELAB 34.83
- Support Level
- ADTX $0.81
- ELAB $1.81
- Resistance Level
- ADTX $1.29
- ELAB $2.33
- Average True Range (ATR)
- ADTX 0.11
- ELAB 0.13
- MACD
- ADTX 0.02
- ELAB -0.04
- Stochastic Oscillator
- ADTX 76.00
- ELAB 11.86
About ADTX Aditxt Inc.
Aditxt Inc is a life sciences company that develops, builds, and grows innovations with a focus on monitoring and modulating the immune system. It develops products designed to induce tolerance to transplanted organs. Its portfolio consists of two programs Adimune and AditxtScore. It firm's immunosuppressive (anti-rejection) drugs have made possible life-saving organ transplantation procedures and blocking of unwanted immune responses in autoimmune diseases. It is also developing a technology called Apoptotic DNA Immunotherapy (ADi) ADI-100, which utilizes a novel approach that mimics, the way bodies naturally induce tolerance to tissues.
About ELAB Elevai Labs Inc.
PMGC Holdings Inc advancing in Medical Aesthetics and Biopharmaceutical Innovation. It specializes in Skin Aesthetics, Obesity, and Metabolic Health business.